SJIM
OGEN icon

St. Johns Investment Management’s Oragenics OGEN Stock Holding History

St. Johns Investment Management’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112 Buy
+200
New +$158 ﹤0.01% 191

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

St. Johns Investment Management's OGEN Position: Q1 2026 in Review

St. Johns Investment Management opened a new position in Oragenics (OGEN) in Q1 2026: 200 shares worth $112. The stake represents ﹤0.01% of the portfolio and ranks #191 among its holdings.

19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • St. Johns Investment Management held 200 shares of Oragenics worth $112 as of Q1 2026.
  • Oragenics was a new St. Johns Investment Management position in Q1 2026.
  • Oragenics made up ﹤0.01% of St. Johns Investment Management's portfolio in Q1 2026, its #191 holding.
  • 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on St. Johns Investment Management's 13F filing for Q1 2026, filed 28 Apr 2026.